These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9085210)

  • 1. Betamimetics in fetal distress: randomised controlled trial.
    Kulier R; Gülmezoĝlu AM; Hofmeyr GJ; Van Gelderen CJ
    J Perinat Med; 1997; 25(1):97-100. PubMed ID: 9085210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hexoprenaline tocolysis for intrapartum fetal distress and acidosis.
    Lipshitz J; Shaver DC; Anderson GD
    J Reprod Med; 1986 Nov; 31(11):1023-6. PubMed ID: 3100782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective randomised trial of atosiban versus hexoprenaline for acute tocolysis and intrauterine resuscitation.
    Afschar P; Schöll W; Bader A; Bauer M; Winter R
    BJOG; 2004 Apr; 111(4):316-8. PubMed ID: 15008765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a beta 2-sympathomimetic drug as a temporizing measure in the treatment of acute fetal distress.
    Lipshitz J
    Am J Obstet Gynecol; 1977 Sep; 129(1):31-6. PubMed ID: 900165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tocolytics for suspected intrapartum fetal distress.
    Kulier R; Hofmeyr GJ
    Cochrane Database Syst Rev; 2000; (2):CD000035. PubMed ID: 10796094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electronic fetal heart rate monitoring: early neonatal outcomes associated with normal rate, fetal stress, and fetal distress.
    Dellinger EH; Boehm FH; Crane MM
    Am J Obstet Gynecol; 2000 Jan; 182(1 Pt 1):214-20. PubMed ID: 10649181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placental transfer of 14C-hexoprenaline.
    Lipshitz J; Broyles K; Whybrew WD; Ahokas RA; Anderson GD
    Am J Obstet Gynecol; 1982 Feb; 142(3):313-5. PubMed ID: 7065021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent versus continuous electronic monitoring in labour: a randomised study.
    Herbst A; Ingemarsson I
    Br J Obstet Gynaecol; 1994 Aug; 101(8):663-8. PubMed ID: 7947499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Betamimetics for inhibiting preterm labour.
    Anotayanonth S; Subhedar NV; Garner P; Neilson JP; Harigopal S
    Cochrane Database Syst Rev; 2004 Oct; (4):CD004352. PubMed ID: 15495104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial of intrapartum electronic fetal heart rate monitoring versus intermittent auscultation.
    Vintzileos AM; Antsaklis A; Varvarigos I; Papas C; Sofatzis I; Montgomery JT
    Obstet Gynecol; 1993 Jun; 81(6):899-907. PubMed ID: 8497353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arg16 homozygosity of the beta2-adrenergic receptor improves the outcome after beta2-agonist tocolysis for preterm labor.
    Landau R; Morales MA; Antonarakis SE; Blouin JL; Smiley RM
    Clin Pharmacol Ther; 2005 Dec; 78(6):656-63. PubMed ID: 16338281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrauterine resuscitation during the second stage of term labour by maternal hyperoxygenation versus conventional care: study protocol for a randomised controlled trial (INTEREST O2).
    Bullens LM; Hulsenboom ADJ; Moors S; Joshi R; van Runnard Heimel PJ; van der Hout-van der Jagt MB; van den Heuvel ER; Guid Oei S
    Trials; 2018 Mar; 19(1):195. PubMed ID: 29566729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal pulse oximetry and wavelet analysis of the fetal heart rate in the evaluation of abnormal cardiotocography tracings.
    Salamalekis E; Siristatidis C; Vasios G; Saloum J; Giannaris D; Chrelias C; Prentza A; Koutsouris D
    J Obstet Gynaecol Res; 2006 Apr; 32(2):135-9. PubMed ID: 16594915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic amnioinfusion for intrapartum fetal distress using a pediatric feeding tube.
    Abdel-Aleem H; Amin AF; Shokry M; Radwan RA
    Int J Gynaecol Obstet; 2005 Aug; 90(2):94-8. PubMed ID: 15913621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of tocolytic drugs to reverse oxytocin-induced uterine hypertonus and fetal distress.
    Lipshitz J; Klose CW
    Obstet Gynecol; 1985 Sep; 66(3 Suppl):16S-18S. PubMed ID: 2862618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The use of ginipral (hexoprenaline) in threatened premature labor, acute fetal hypoxia and uncoordinated labor activity].
    Strizhova NV; Hamdan S; Tuminova SN; Komarova EE
    Akush Ginekol (Mosk); 1993; (2):30-2. PubMed ID: 8048666
    [No Abstract]   [Full Text] [Related]  

  • 17. Newborn outcomes in british columbia after caesarean section for non-reassuring fetal status.
    Jenniskens K; Janssen PA
    J Obstet Gynaecol Can; 2015 Mar; 37(3):207-213. PubMed ID: 26001867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intrauterine pressure and fetal and maternal heart rate on administration of the betamimetic agent, hexoprenaline during labour (author's transl)].
    Bernaschek G; Hondros K; Schaller A
    Wien Klin Wochenschr; 1981 Sep; 93(17):541-7. PubMed ID: 7303700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central fetal monitoring: effect on perinatal outcomes and cesarean section rate.
    Withiam-Leitch M; Shelton J; Fleming E
    Birth; 2006 Dec; 33(4):284-8. PubMed ID: 17150066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine and cardiovascular effects of fenoterol and hexoprenaline in prostaglandin F2 alpha-induced labor in humans.
    Lipshitz J; Lipshitz EM
    Obstet Gynecol; 1984 Mar; 63(3):396-400. PubMed ID: 6583599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.